Cardiac Dimensions Lands $20,000,000 New Funding Round

  • Feed Type
  • Date
    4/17/2014
  • Company Name
    Cardiac Dimensions
  • Mailing Address
    5540 Lake Washington Blvd. NE Kirkland, WA 98033 USA
  • Company Description
    Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of congestive heart failure (CHF) and related conditions.
  • Website
    http://www.cardiacdimensions.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the financing will be used to initiate a multi-national, blinded, randomized clinical trial, REDUCE-FMR, involving up to 20 hospitals, with the objective to firmly establish CARILLON as the gold standard therapy in the treatment of functional mitral regurgitation (FMR).
  • M&A Terms
  • Venture Investor
  • Venture Investor

By posting a comment, you agree to our terms and conditions.